Continuous Glucose Monitoring Device (CGMD) Market Share and Business Opportunities 2030
Continuous Glucose Monitoring Device (CGMD) Market: Size and Share
-
CAGR (2022 - 2030)14.1% -
Market Size 2022
US$ 9.8 Billion -
Market Size 2030
US$ 28.5 Billion
Market Dynamics
- Rising incidence of chronic diseases
- Demand for early diagnostic tools
- Adoption of molecular diagnostics
- Advancements in lab automation
- Growth in point-of-care diagnostic testing
- Expansion into emerging healthcare markets
Market Segmentation
Product - Sensors
- Transmitters
- Receivers
Application - Type 1 Diabetes and Type 2 Diabetes
Testing Site - Fingertip Testing and Alternate Site Testing
End User - Hospitals & Clinics and Self/Homecare
Continuous Glucose Monitoring Device (CGMD) Market Players Density: Understanding Its Impact on Business Dynamics
The Continuous Glucose Monitoring Device (CGMD) Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Continuous Glucose Monitoring Device (CGMD) Market are:
- B. Braun SE
- F. Hoffmann-La-Roche Ltd
- LifeScan Inc
- Medtronic
- Abbott Laboratories
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Continuous Glucose Monitoring Device (CGMD) Market top key players overview
Get Free Sample For